Lyophilized platelets; Nearing clinical trials

Platelets

Volumn 8, Issue 6, 1997, Pages 436-437

  Bode, A P ^a   Read, M S ^b   Summaria, L ^c   Lust, R M ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Centeon   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFORMALDEHYDE;

ANIMAL CELL; ANIMAL EXPERIMENT; BLEEDING TIME; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; FREEZE DRYING; HEMOSTASIS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; VIRUS INACTIVATION;

EID: 0031449859     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Bellamy RF. The causes of death in conventional land warfare: implications for combat casualty care research. Milit Med 1984; 149: 55-62.
2. Read MS, Reddick RL, Bode AP, et al. Preservation of hemostatic and structural properties of rehydrated lyophilized platelets; potential for long-term storage of dried platelets for transfusion. PNAS 1995; 92: 397-401.
3. Bode AP. Preclinical testing of lyophilized platelets as a product for transfusion medicine. Transfus Sci 1995; 16: 183-5.
4. Holme S, Heaton WA, Courtright M. Improved in vivo and in vitro viability of platelet concentrates stored for seven days in a platelet additive solution. Br J Hematol 1987; 66: 233-8.
5. Blajchman MA, Lee DH. The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes. Transfus Med Rev 1997; 11: 95-105.
6. Bode AP, Blajchman MA, Bardossy L, Read MS. Hemostatic properties of human lyophilized platelets in a thrombocytopenic rabbit model and a simulated bleeding time device. Blood 1994; 84(suppl 1): 464a.